Most Popular Brands: Lioresal Oral
See also: Baclofen Intrathecal, Lioresal Intrathecal
Baclofen is a skeletal muscle relaxant and antispastic agent used for the treatment of reversible spasticity associated with multiple sclerosis or spinal cord lesions.
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Stiffness/Spasticity | 277 |
|
|
|
|
|
42 |
| Cramps | 29 |
|
|
|
|
7 | |
| Other | 28 |
|
|
|
|
|
6 |
| Fasciculations | 27 |
|
|
|
4 | ||
| disease-related symptoms | 15 | 0 | |||||
| Muscle spasms | 12 |
|
1 |
See all 399 patients currently taking Baclofen
Mouse over the table for more information
Top 10 dosages based on patients currently taking Baclofen. See all 45 dosages ►
| 0.05mg/mL as needed | 10mg as needed | 20 mg as needed | 20mg as needed | 2 10mg as needed | as needed | daily | 0.05 mg daily | 0.05 mg/mL daily | 0.075 mg daily | 0.15 mg daily | 0.225 mg daily | 0.35 mg daily | 0.5 mg daily | 2 daily | 2 mg daily | 3 mg daily | 5 mg daily | 5.5 mg daily | 8 daily | 10 mg daily | 15 mg daily | 20 mg daily | 25 mg daily | 30 mg daily | 40 mg daily | 45 mg daily | 50 mg daily | 60 daily | 60 mg daily | 70 g daily | 70 mg daily | 75 mg daily | 80 daily | 80 mg daily | 90 daily | 90 mg daily | 100 mg daily | 120 mg daily | 140 mg daily | 150 mg daily | 167 mcg daily | 180 mg daily | 900 mcg daily | 1240 mcg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
3
|
1
|
1
|
1
|
1
|
21
|
2
|
1
|
1
|
4
|
1
|
1
|
3
|
1
|
1
|
1
|
4
|
1
|
1
|
41
|
6
|
70
|
1
|
59
|
43
|
1
|
17
|
1
|
48
|
1
|
3
|
3
|
1
|
29
|
1
|
5
|
6
|
8
|
1
|
1
|
1
|
1
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
28 | 39% |
|
|
Did not seem to work
|
26 | 36% |
|
|
Other
|
10 | 14% |
|
|
Doctor's advice
|
8 | 11% |
|
|
Not indicated
|
3 | 4% |
|
|
Personal research
|
2 | 3% |
|
|
Course of treatment ended
|
1 | 1% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 20, 2010.